EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B10

Ensembl ID : ENSFHEG00000023386
Gene Symbol: LOC105937510
3 Cross references
348 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSFHEG00000023385
Gene Symbol: LOC105937511
3 Cross references
350 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSFHEG00000004062
Gene Symbol: LOC105939200
3 Cross references
202 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSFHEG00000012842
Gene Symbol: LOC105919214
3 Cross references
192 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSFHEG00000021618
Gene Symbol: LOC105931407
3 Cross references
175 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSFHEG00000000630
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:

Amyloid Beta A4 Protein

Ensembl ID : ENSFHEG00000017717
Gene Symbol: LOC105934899
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSFHEG00000020327
Gene Symbol: APP
4 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSFHEG00000002096
Gene Symbol: LOC105931285
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSFHEG00000002341
Gene Symbol: AR
4 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSFHEG00000017333
Gene Symbol: AGTR1
3 Cross references
203 Possible Orthologues:

Anti-Apoptotic Protein Nr13

Ensembl ID : ENSFHEG00000014109
Gene Symbol: LOC105916409
3 Cross references
129 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).